|
|
|
![]() |
![]() ![]() |
![]() |
|
||
![]() |
![]() |
Upside to 200 short termPrior to final FDA decision it is quite possible this hits 200 moving in to May. Todays 22 year end financials update included no ADCOM and apparently no clinical safety questions. After approval where does it go? 250 is in play. 300? I’m less convinced of the 300 potential but a buyout could easily be at 300. A great report from DI today and blue skies ahead. |
![]() ![]() ![]() ![]() |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
14502 | Re: Upside to 200 short term | schmiggins | 0 | 3/1/2023 6:10:00 PM |